- $926.34m
- $1.29bn
- $1.10bn
PetIQ Inc reports results for the quarter ended in June - Earnings Summary
Brief: Petiq Inc - QTRLY Net Income Per Share Attributable To Petiq, Inc. Class A Common Stock $0.14
Brief: Petiq Inc - John Newland To Retire After More Than Seven Years As CFO
PetIQ Inc reports results for the quarter ended in March - Earnings Summary
Brief: Petiq Says Q1 Sales Rose 36.2 Percent To $254.3 Million
PetIQ Inc expected to post earnings of 14 cents a share - Earnings Preview
Brief: Petiq, Inc. Enters Into New $425 Million Credit Facilities
Brief: Petiq Inc -Co's Subsidiary Entered Into An Asset-Based Credit Agreement
Veterinary drugs sales set to grow in Q1: Guggenheim
Moody's assigns first time B3 CFR to PetIQ, LLC; outlook stable
Brief: PetIQ Reports Q4 And Full Year 2020 Financial Results
Brief: PetIQ Board Increased Size Of Board From 5 To 7 Directors
Brief: Petiq Board Takes Action To Reduce Size To Five Directors
PetIQ: Hits 6-mth low after Q3 sales misses estimates on pandemic hit
Brief: Petiq, Inc. Reports Third Quarter 2020 Financial Results
Brief: Petiq Inc - Has Re-Opened Approximately 70% Of Its Wellness Centers And 60% Of Its Community Clinics
PetIQ: Drops as Q3 sales forecast disappoints
Brief: PetIQ Reports Record Second Quarter 2020 Financial Results
Brief: PetIQ Receives FTC Approval To Close Acquisition Of The Capstar Portfolio Of Products